IceCure (ICCM) VP HR Dotan Merav Nir Receives RSU Award

What Happened

• Dotan Merav Nir, Vice President, Human Resources of IceCure Medical Ltd. (ICCM), was granted 73,890 restricted share units (RSUs) on August 14, 2026. The Form 4 reports the acquisition price as $0.00 (typical for RSU grants).
• These RSUs are compensation awards (not an open-market purchase or sale) and therefore do not represent a cash investment by the insider.

Key Details

• Transaction date: August 14, 2026; Form 4 filed August 17, 2026 (timely).
• Grant reported: 73,890 RSUs at $0.00.
• Holdings reported after the grant: 17 ordinary shares and 76,168 RSUs in total (73,890 + 758 + 1,080 + 440 RSUs). Except for the 25% tranche of the 758 RSUs granted July 2, 2024 (which vested July 29, 2026), the RSUs listed remain unvested as of August 13, 2026.
• Key vesting for the 73,890 RSUs: 25% vests on August 11, 2027; the remaining 75% vests in twelve equal quarterly installments of 6.25% thereafter.
• Other grants and vesting: 758 RSUs (July 2, 2024), 1,080 RSUs (Nov 5, 2025), and 440 RSUs (Mar 16, 2026) each follow a 25% first-tranche vest then remaining 75% in quarterly 6.25% installments; holdings adjusted for the issuer’s 1-for-30 reverse share split.

Context

• RSU grants are standard compensation and do not necessarily signal immediate buying or selling intent; they vest over time and typically convert to shares when vested.
• No sale, purchase or option exercise occurred in this filing—this is an award/compensation grant (transaction code A).
• Filing was timely (filed within the SEC window).